Reaffirms FY25 adjusted EBITDA view $190M-$210M. Lowers FY25 capital expenditures view to ~$175M from ~$225 million in the previous guidance.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FRPT: